Evidence map›Paper›PMID 34205384›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Sigma 1 Receptor Co-Localizes with NRF2 in Retinal Photoreceptor Cells.

Shannon R Barwick, Mevish S Siddiq, Jing Wang, Haiyan Xiao, Brendan Marshall, Elizabeth Perry, Sylvia B Smith

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Sigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. SIGMAR1 Confers Innate Resilience against Neurodegeneration.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shannon R BarwickDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Mevish S SiddiqDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Jing WangDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Haiyan XiaoDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Brendan MarshallDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Elizabeth PerryDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Sylvia B SmithDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Augusta University · US

Funding

Sigma 1 Receptor: a novel therapeutic target for retinal degenerationR01EY028103 · NEI · AUGUSTA UNIVERSITY · PI SMITH, SYLVIA B. · 2017 to 2019
$1.2M
Foundation Fighting Blindness TA-NMT-0617-0721-AUGNEI NIH HHS R01EY028103, P30EY031631
6 · The paper itself

Abstract

Sigma 1 receptor (Sig1R), a modulator of cell survival, has emerged as a novel target for retinal degenerative disease. Studies have shown that activation of Sig1R, using the high affinity ligand (+)-pentazocine ((+)-PTZ), improves cone function in a severe retinopathy model. The rescue is accompanied by normalization of levels of NRF2, a key transcription factor that regulates the antioxidant response. The interaction of Sig1R with a number of proteins has been investigated; whether it interacts with NRF2, however, is not known. We used co-immunoprecipitation (co-IP), proximity ligation assay (PLA), and electron microscopy (EM) immunodetection methods to investigate this question in the 661W cone photoreceptor cell line. For co-IP experiments, immune complexes were precipitated by protein A/G agarose beads and immunodetected using anti-NRF2 antibody. For PLA, cells were incubated with anti-Sig1R polyclonal and anti-NRF2 monoclonal antibodies, then subsequently with (-)-mouse and (+)-rabbit PLA probes. For EM analysis, immuno-EM gold labeling was performed using nanogold-enhanced labeling with anti-NRF2 and anti-Sig1R antibodies, and data were confirmed using colloidal gold labeling. The co-IP experiment suggested that NRF2 was bound in a complex with Sig1R. The PLA assays detected abundant orange fluorescence in cones, indicating that Sig1R and NRF2 were within 40 nm of each other. EM immunodetection confirmed co-localization of Sig1R with NRF2 in cells and in mouse retinal tissue. This study is the first to report co-localization of Sig1R-NRF2 and supports earlier studies implicating modulation of NRF2 as a mechanism by which Sig1R mediates retinal neuroprotection.

Indexed as

cone cellselectron microscopy (EM) immunodetectionmouseNRF2oxidative stresspentazocinephotoreceptor cellsretinal degenerationretinal neuroprotectionsigma receptor

Identifiers

PMID34205384
PMCPMC8234060
OpenAlexW3173448041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.